Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Huttner

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
The Lancet. Microbe|May 11, 2022
Dexamethasone and remdesivir: finding method in the COVID-19 madnessPauline Vetter, Laurent Kaiser, Alexandra Calmy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2023
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent womenStijn Bex, Antonio Leidi, Christophe Marti, et al.
International Journal of Antimicrobial Agents|May 12, 2020
How preclinical infection models help define antibiotic doses in the clinicThomas Tängdén, Carina Vingsbo Lundberg, Lena E Friberg, et al.
Infectious Diseases & Clinical Microbiology|March 11, 2026
Beyond Parity: Gender Inequities and Recommendations in Infectious Diseases and Clinical Microbiology ResearchMüge Çevik, Katharina Last, Cihan Papan, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2013
Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs systemBenedikt Huttner, Makoto Jones, Angela Huttner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Abandoned trials in infectious diseases and clinical microbiology. A call for actionLuigia Scudeller, Angela Huttner, Mical Paul, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2021
How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort studyAnne Rossel, Kimberly P M Zandberg, Werner C Albrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Abandoned trials in infection diseases and clinical microbiology: a call for actionLuigia Scudeller, Angela Huttner, Mical Paul, et al.
EFORT Open Reviews|January 10, 2022
A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safetyJoseph Genevière, Shawna McCallin, Angela Huttner, et al.
JAMA Network Open|May 13, 2022
Patient and Proxy Recall After Providing Written or Oral Informed Consent to Participate in an Interventional TrialAngela Huttner, Elodie von Dach, Virginie Prendki, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
The Lancet. Microbe|May 11, 2022
Dexamethasone and remdesivir: finding method in the COVID-19 madnessPauline Vetter, Laurent Kaiser, Alexandra Calmy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2023
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent womenStijn Bex, Antonio Leidi, Christophe Marti, et al.
International Journal of Antimicrobial Agents|May 12, 2020
How preclinical infection models help define antibiotic doses in the clinicThomas Tängdén, Carina Vingsbo Lundberg, Lena E Friberg, et al.
Infectious Diseases & Clinical Microbiology|March 11, 2026
Beyond Parity: Gender Inequities and Recommendations in Infectious Diseases and Clinical Microbiology ResearchMüge Çevik, Katharina Last, Cihan Papan, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2013
Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs systemBenedikt Huttner, Makoto Jones, Angela Huttner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Abandoned trials in infectious diseases and clinical microbiology. A call for actionLuigia Scudeller, Angela Huttner, Mical Paul, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2021
How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort studyAnne Rossel, Kimberly P M Zandberg, Werner C Albrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Abandoned trials in infection diseases and clinical microbiology: a call for actionLuigia Scudeller, Angela Huttner, Mical Paul, et al.
EFORT Open Reviews|January 10, 2022
A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safetyJoseph Genevière, Shawna McCallin, Angela Huttner, et al.
JAMA Network Open|May 13, 2022
Patient and Proxy Recall After Providing Written or Oral Informed Consent to Participate in an Interventional TrialAngela Huttner, Elodie von Dach, Virginie Prendki, et al.
Pageof 11